ABCG2 and lip and oral cavity carcinoma: Furthermore, co-expressions of GBP5/CD166 (AHR = 2.48, CI = 1.08–5.74, p = 0.033, Table 5) and GBP5/ ABCG2 (AHR = 2.65, CI = 1.25–5.61, p = 0.011, Table 5) genes are associated with DFS in oral cancer patients from TCGA database.